CheemaZZHassanESiddiqN. Suzetrigine and the evolving landscape of non-opioid analgesia. Br J Pain. 2026; 20494637261418201. https://doi.org/10.1177/20494637261418201
2.
Dib-HajjSDYangYBlackJA, et al.The Na(V)1.7 sodium channel: from molecule to man. Nat Rev Neurosci2013; 14(1): 49–62. https://doi.org/10.1038/nrn3404
3.
PriestBTKaczorowskiGJ. Subtype-selective sodium channel blockers promise a new era of pain research. Proc Natl Acad Sci U S A2007; 104(20): 8205–8206. https://doi.org/10.1073/pnas.0703091104
4.
ZangerUMSchwabM. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther2013; 138(1): 103–141. https://doi.org/10.1016/j.pharmthera.2012.12.007
5.
ChouRGordonDBde Leon-CasasolaOA, et al.Management of postoperative pain: a clinical practice guideline from the American pain society, the American society of regional anesthesia and pain medicine, and the American society of anesthesiologists' committee on regional anesthesia, executive committee, and administrative council. J Pain2016; 17(2): 131–157. https://doi.org/10.1016/j.jpain.2015.12.008
WaxmanSGZamponiGW. Regulating excitability of peripheral afferents: emerging ion channel targets. Nat Neurosci2014; 17(2): 153–163. https://doi.org/10.1038/nn.3602
8.
MylesPSMylesDBGalagherW, et al.Measuring acute postoperative pain using the visual analog scale: the minimal clinically important difference and patient acceptable symptom state. Br J Anaesth2017; 118(3): 424–429. https://doi.org/10.1093/bja/aew466
